Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kindred Biosciences announces pricing of public offering

Thursday, 3 Apr 2014 09:04am EDT 

Kindred Biosciences Inc:Prices public offering of 3 mln shares of common stock at $18 per share for total offering of $54 mln.To use net proceeds for acquisitions of additional product candidates or other complementary assets or businesses.To accelerate and expand research and development of current product candidates and for general corporate and working capital purposes.Leerink Partners LLC is lead book-running manager.BMO Capital Markets Corp and Guggenheim Securities LLC as joint book-running managers. 

Related Company News

Company Quote

0.1 +1.02%
26 Nov 2014